We study how pathogen-specific antibody repertoires are generated, remodeled, and deployed — and apply that knowledge to engineer personalized vaccines and immunotherapies.
면역공학 연구실은 항체 레퍼토어를 분자 수준에서 분석하고, 이를 바탕으로 항체 공학과 항체 발굴, 백신·항체 치료제 설계를 연구합니다.
Two complementary technologies that, together, reveal both the sequences and the abundances of the antibodies that protect us — connecting the B cells that encode antibodies with the antibody proteins actually circulating in serum.
Next-generation sequencing of antibody (BCR) transcripts from B cells, with native VH:VL heavy/light chain pairing, captures the full sequence diversity of the antibody repertoire.
Affinity purification followed by high-resolution proteomic mass spectrometry quantifies the antibodies actually secreted into serum, revealing which clones dominate the protective response.
Using high-throughput sequencing of B cell transcripts and high-resolution mass spectrometry, we map the dynamics of antibody repertoires in infectious disease — with an emphasis on influenza and SARS-CoV-2 — to design therapeutics tailored to maximize antibody-mediated protection.
Explore the platform →We build technologies to screen antibody function on native mammalian cell lines, facilitating discovery of effective antibodies from large libraries and accelerating development of novel therapeutics for critical unmet medical needs.
See the discovery platform →By examining the diversity and function of the antibody repertoire, we design immunogens that focus immune responses toward protective epitopes, enabling antibody-guided rational vaccine design and next-generation vaccines tailored to individuals.
Explore protein engineering →